Read more about the article Andira Pharmaceuticals Appoints Jonathan Primer as Lead Commercial Advisor for Revolutionary Infection Control Technology Matrix3™
Uncategorized

Andira Pharmaceuticals Appoints Jonathan Primer as Lead Commercial Advisor for Revolutionary Infection Control Technology Matrix3™

Vancouver, British Columbia, Canada – Andira Pharmaceuticals is delighted to announce the appointment of Jonathan Primer, a global medical industry expert, as Lead Commercial Advisor. Mr. Primer will play a…

Comments Off on Andira Pharmaceuticals Appoints Jonathan Primer as Lead Commercial Advisor for Revolutionary Infection Control Technology Matrix3™
March 5, 2024
Read more about the article Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
put a patented stamp on document. intellectual property protection
Uncategorized

Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections

Opportunity to invest in Canadian health science firm pioneering a new generation of patented therapeutics for drug-resistant infection is now open globally to eligible investors. SAN FRANCISCO, AUGUST 2023 –…

Comments Off on Andira Pharmaceuticals’ US Patent Allowed in Breakthrough Therapeutic Treatment to Address Deadly Antibiotic-Resistant Infections
August 14, 2023